Literature DB >> 20544820

Chemical inducers and transcriptional markers of oligodendrocyte differentiation.

Lara Joubert1, Isabelle Foucault, Yves Sagot, Lilia Bernasconi, François Duval, Chantal Alliod, Marie-José Frossard, Rosanna Pescini Gobert, Marie-Laure Curchod, Catherine Salvat, Anthony Nichols, Sandrine Pouly, Christian Rommel, Arthur Roach, Rob Hooft van Huijsduijnen.   

Abstract

Oligodendrocytes generate and maintain myelin, which is essential for axonal function and protection of the mammalian central nervous system. To advance our molecular understanding of differentiation by these cells, we screened libraries of pharmacologically active compounds and identified inducers of differentiation of Oli-neu, a stable cell line of mouse oligodendrocyte precursors (OPCs). We identified four broad classes of inducers, namely, forskolin/cAMP (protein kinase A activators), steroids (glucocorticoids and retinoic acid), ErbB2 inhibitors, and nucleoside analogs, and confirmed the activity of these compounds on rat primary oligodendrocyte precursors and mixed cortical cultures. We also analyzed transcriptional responses in the chemically induced mouse and rat OPC differentiation processes and compared these with earlier studies. We confirm the view that ErbB2 is a natural signaling component that is required for OPC proliferation, whereas ErbB2 inhibition or genetic knockdown results in OPC differentiation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20544820     DOI: 10.1002/jnr.22434

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  28 in total

1.  Plasticity of the myelination genomic fabric.

Authors:  Sanda Iacobas; Neil M Thomas; Dumitru A Iacobas
Journal:  Mol Genet Genomics       Date:  2012-01-13       Impact factor: 3.291

2.  Phenotypic changes, signaling pathway, and functional correlates of GPR17-expressing neural precursor cells during oligodendrocyte differentiation.

Authors:  Marta Fumagalli; Simona Daniele; Davide Lecca; Philip R Lee; Chiara Parravicini; R Douglas Fields; Patrizia Rosa; Flavia Antonucci; Claudia Verderio; M Letizia Trincavelli; Placido Bramanti; Claudia Martini; Maria P Abbracchio
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

3.  Live imaging of targeted cell ablation in Xenopus: a new model to study demyelination and repair.

Authors:  Ferdinand Kaya; Abdelkrim Mannioui; Albert Chesneau; Sowmya Sekizar; Emmanuelle Maillard; Chantal Ballagny; Ludivine Houel-Renault; David Dupasquier; Odile Bronchain; Isabelle Holtzmann; Anne Desmazieres; Jean-Léon Thomas; Barbara A Demeneix; Peter J Brophy; Bernard Zalc; Andre Mazabraud
Journal:  J Neurosci       Date:  2012-09-12       Impact factor: 6.167

4.  N-acetylaspartate (NAA) and N-acetylaspartylglutamate (NAAG) promote growth and inhibit differentiation of glioma stem-like cells.

Authors:  Patrick M Long; John R Moffett; Aryan M A Namboodiri; Mariano S Viapiano; Sean E Lawler; Diane M Jaworski
Journal:  J Biol Chem       Date:  2013-07-24       Impact factor: 5.157

5.  The Orphan G Protein-coupled Receptor GPR17 Negatively Regulates Oligodendrocyte Differentiation via Gαi/o and Its Downstream Effector Molecules.

Authors:  Katharina Simon; Stephanie Hennen; Nicole Merten; Stefanie Blättermann; Michel Gillard; Evi Kostenis; Jesus Gomeza
Journal:  J Biol Chem       Date:  2015-11-30       Impact factor: 5.157

Review 6.  Remyelination therapies: a new direction and challenge in multiple sclerosis.

Authors:  Jason R Plemel; Wei-Qiao Liu; V Wee Yong
Journal:  Nat Rev Drug Discov       Date:  2017-07-07       Impact factor: 84.694

Review 7.  Steroids and injury to the developing brain: net harm or net benefit?

Authors:  Shadi N Malaeb; Barbara S Stonestreet
Journal:  Clin Perinatol       Date:  2014-03       Impact factor: 3.430

8.  A regenerative approach to the treatment of multiple sclerosis.

Authors:  Brian R Lawson; Peter G Schultz; Luke L Lairson; Vishal A Deshmukh; Virginie Tardif; Costas A Lyssiotis; Chelsea C Green; Bilal Kerman; Hyung Joon Kim; Krishnan Padmanabhan; Jonathan G Swoboda; Insha Ahmad; Toru Kondo; Fred H Gage; Argyrios N Theofilopoulos
Journal:  Nature       Date:  2013-10-09       Impact factor: 49.962

Review 9.  Promoting remyelination for the treatment of multiple sclerosis: opportunities and challenges.

Authors:  Yueting Zhang; Taylor B Guo; Hongtao Lu
Journal:  Neurosci Bull       Date:  2013-04-05       Impact factor: 5.203

10.  Inhibition of endogenous phosphodiesterase 7 promotes oligodendrocyte precursor differentiation and survival.

Authors:  E M Medina-Rodríguez; F J Arenzana; J Pastor; M Redondo; V Palomo; R García de Sola; C Gil; A Martínez; A Bribián; F de Castro
Journal:  Cell Mol Life Sci       Date:  2013-05-10       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.